Ex-vivo Hypotermic Perfusion in Patients with Hepatocellular Carcinoma to Reduce the Incidence of Tumor Recurrence

CompletedOBSERVATIONAL
Enrollment

237

Participants

Timeline

Start Date

June 3, 2022

Primary Completion Date

January 8, 2024

Study Completion Date

January 8, 2024

Conditions
Liver CarcinomaLiver TransplantTumor RecurrenceHepato Cellular Carcinoma (HCC)Hypothermic Oxygenated Machine Perfusion
Interventions
PROCEDURE

Hypothermic Oxygented Perfusion

HOPE start by flushing the organ at low flow values (30 ml/min) with new oxygenated perfusion fluid (cold Belzer MPS solution) during back-table preparation. Hepatic perfusion was performed through the vein leads to a pressure of 3-5 mmHg. Organ were treated with continuous HOPE until transplant and the perfusion was continuously monitored and data downloaded in a USB memory.

PROCEDURE

Static Cold Storage

Liver grafts are stored in sterile organ bags with cold Belzer or Celsior solution and kept in ice at 4°C.

Trial Locations (1)

40138

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna

All Listed Sponsors
lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER